Heart failure and arrhythmias together pose a critical healthcare issue with high risks of morbidity and mortality globally. Emerging evidence underscores ...

A new publication from Genes & Diseases; DOI 10.1016/j.gendis.2024.101284, discusses the effect of long-term administration ...

(KTAL/KMSS) – A new treatment option for patients with uncontrollable high ... Hypertension can put one at risk for ...

The different associations of standing hypertension and systolic orthostatic increases in BP with CVD raises concerns about ...

AZD-3427 is commercialized by AstraZeneca, with a leading Phase II program in Congestive Heart Failure (Heart Failure).

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

After over a decade of research, experts have unveiled a concerning truth for individuals taking certain hormone medications. A recent study published in the medical journal BMJ has exposed the ...

There are many types and combinations of drugs used to treat a myocardial infarction (MI ... Examples of diuretics include: Nitrates treat chest pain (angina), heart failure, and other cardiovascular ...

"One of the most striking findings was that GLP-1 medications had a lower risk than alcohol-use disorder medications we use," study co-author Markku Lähteenvuo, a docent of forensic psychiatry at ...

It should be appreciated that clinical heart failure with preserved systolic function (diastolic heart failure) can be caused by heterogeneous pathophysiologic conditions. Hypertrophic ...

Hyperglycemia accelerated diastolic dysfunction and HFpEF onset associated with reduced arterial flow and left ventricular remodeling. Therefore, the pathological substrates contributing to HFpEF ...